Paul Grof, MD, PhD, FRCPC
"Lithium and Bipolar Illness: The risky business of short-selling gold-standard, evidence-based treatment"
In all 30+ guidelines for bipolar disorder treatment, lithium is placed as number one, the treatment of choice. So why is it prescribed less and less everywhere? We offer an explanation based on three significant misunderstandings about lithium treatment. These three issues are confusing clinical practice.
CME/CE credit for Psychiatry Grand Rounds is only available during the live feed time and for a brief time immediately following. The code for this week's session is displayed at the opening and closing of the meeting and also in the Chair's Office Zoom Account Name during the meeting.
For CME/CE information about this session, visit: vumc.cloud-cme.com/course/courseoverview?P=0&EID=26489
This talk is sponsored by the Orr Lecture Fund, Department of Psychiatry and Behavioral Sciences. This educational activity received no commercial support.